• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy.

作者信息

Sampson Hugh A, Leung Donald Y M, Burks A Wesley, Lack Gideon, Bahna Sami L, Jones Stacie M, Wong Dennis A

出版信息

J Allergy Clin Immunol. 2011 May;127(5):1309-10.e1. doi: 10.1016/j.jaci.2011.01.051. Epub 2011 Mar 11.

DOI:10.1016/j.jaci.2011.01.051
PMID:21397314
Abstract
摘要

相似文献

1
A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy.一项关于Xolair（奥马珠单抗）治疗花生过敏的II期随机双盲平行组安慰剂对照口服食物激发试验。
J Allergy Clin Immunol. 2011 May;127(5):1309-10.e1. doi: 10.1016/j.jaci.2011.01.051. Epub 2011 Mar 11.
2
Changes in peanut-specific T-cell clonotype with oral immunotherapy.口服免疫疗法对花生特异性T细胞克隆型的影响。
J Allergy Clin Immunol. 2015 Jun;135(6):1636-8. doi: 10.1016/j.jaci.2015.03.010. Epub 2015 Apr 28.
3
Recurrent peanut allergy may not be prevented by continued peanut ingestion.持续摄入花生可能无法预防复发性花生过敏。
Int Arch Allergy Immunol. 2008;147(3):260-2. doi: 10.1159/000142051. Epub 2008 Jul 2.
4
Successful oral tolerance induction in severe peanut allergy.在严重花生过敏中成功诱导口服耐受。
Allergy. 2009 Aug;64(8):1218-20. doi: 10.1111/j.1398-9995.2009.01982.x. Epub 2009 Feb 17.
5
Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions.口服免疫疗法治疗花生过敏：接受肾上腺素治疗的过敏反应的多实践经验。
J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):91-6. doi: 10.1016/j.jaip.2013.10.001.
6
A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.奥马珠单抗辅助高风险花生过敏患者快速口服脱敏的初步研究。
J Allergy Clin Immunol. 2013 Dec;132(6):1368-74. doi: 10.1016/j.jaci.2013.09.046. Epub 2013 Oct 28.
7
Administration of a probiotic with peanut oral immunotherapy: A randomized trial.口服花生免疫治疗联合益生菌治疗：一项随机试验。
J Allergy Clin Immunol. 2015 Mar;135(3):737-44.e8. doi: 10.1016/j.jaci.2014.11.034. Epub 2015 Jan 13.
8
Mixed antibody and T cell responses to peanut and the peanut allergens Ara h 1, Ara h 2, Ara h 3 and Ara h 6 in an oral sensitization model.在口服致敏模型中对花生以及花生过敏原Ara h 1、Ara h 2、Ara h 3和Ara h 6的混合抗体和T细胞反应。
Clin Exp Allergy. 2004 Sep;34(9):1422-8. doi: 10.1111/j.1365-2222.2004.02062.x.
9
Lipid transfer protein (Ara h 9) as a new peanut allergen relevant for a Mediterranean allergic population.脂质转运蛋白（Ara h 9）作为一种与地中海过敏人群相关的新型花生过敏原。
J Allergy Clin Immunol. 2009 Oct;124(4):771-8.e5. doi: 10.1016/j.jaci.2009.06.008. Epub 2009 Aug 8.
10
Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization.经皮暴露于花生蛋白会阻止口服耐受并增强过敏致敏。
Clin Exp Allergy. 2005 Jun;35(6):757-66. doi: 10.1111/j.1365-2222.2005.02260.x.

引用本文的文献

1
Omalizumab in food allergy: Risks and benefits.奥马珠单抗治疗食物过敏：风险与益处。
J Food Allergy. 2024 Aug 1;7(1):7-13. doi: 10.2500/jfa.2025.7.250004. eCollection 2024 Aug.
2
Advances in Food Allergy Immunotherapy: Current Strategies and Role of Antibodies Isotypes.食物过敏免疫疗法的进展：当前策略及抗体亚型的作用
Cells. 2025 Jun 14;14(12):900. doi: 10.3390/cells14120900.
3
Biologics in IgE-mediated food allergy: A systematic review and meta-analysis of interventional studies.IgE介导的食物过敏中的生物制剂：干预性研究的系统评价和荟萃分析
World Allergy Organ J. 2025 May 27;18(7):101069. doi: 10.1016/j.waojou.2025.101069. eCollection 2025 Jul.
4
Socioenvironmental factors associated with shrimp allergy and shrimp sensitization in a large and diverse patient population and cohort study from metropolitan Detroit.在一项来自底特律大都市的大型多样化患者群体及队列研究中，与虾过敏和虾致敏相关的社会环境因素。
J Allergy Clin Immunol Glob. 2025 May 8;4(3):100492. doi: 10.1016/j.jacig.2025.100492. eCollection 2025 Aug.
5
Omalizumab in Food Allergy in Children: Current Evidence and Future Perspectives.奥马珠单抗用于儿童食物过敏：当前证据与未来展望
Life (Basel). 2025 Apr 22;15(5):681. doi: 10.3390/life15050681.
6
Scientific developments in understanding food allergy prevention, diagnosis, and treatment.在理解食物过敏预防、诊断和治疗方面的科学进展。
Front Immunol. 2025 Apr 22;16:1572283. doi: 10.3389/fimmu.2025.1572283. eCollection 2025.
7
Efficacy of omalizumab in food allergic adults - A retrospective analysis.奥马珠单抗对食物过敏成人的疗效——一项回顾性分析。
World Allergy Organ J. 2025 Apr 3;18(4):101048. doi: 10.1016/j.waojou.2025.101048. eCollection 2025 Apr.
8
GALEN ANACARE consensus statement: Potential of omalizumab in food allergy management.盖伦过敏症临床共识声明：奥马珠单抗在食物过敏管理中的潜力
Clin Transl Allergy. 2024 Nov;14(11):e70002. doi: 10.1002/clt2.70002.
9
Omalizumab reduces anaphylactic reactions and allows food introduction in food-allergic in children with severe asthma: An observational study.奥马珠单抗可减少过敏反应并使重度哮喘合并食物过敏的儿童能够引入食物：一项观察性研究。
Allergy. 2025 Apr;80(4):1074-1085. doi: 10.1111/all.16314. Epub 2024 Sep 16.
10
Omalizumab for the reduction of allergic reactions to foods: a narrative review.奥马珠单抗用于减少食物过敏反应：一项叙述性综述。
Front Allergy. 2024 May 28;5:1409342. doi: 10.3389/falgy.2024.1409342. eCollection 2024.